Laura Hutchins, a hematologist-oncologist at the University of Arkansas for Medical Sciences who specializes in breast cancer, melanoma and brain cancer, has been appointed interim director for the UAMS Winthrop P. Rockefeller Cancer Institute, effective immediately.
Steven Rosenberg received the 2018 Jacobson Innovation Award of the American College of Surgeons.
Penn State Health and Highmark Health, announced plans for a strategic partnership aimed at securing the future of health care in the region.
NCI has renewed City of Hope Comprehensive Cancer Center's five-year Cancer Center Support Grant, with an overall rating of “outstanding.”
Stephen Forman, the Francis & Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic Cell Transplantation, was inducted as a member of the Association of American Physicians.
City of Hope Provost and Chief Scientific Officer Steven Rosen was inducted into the College of Fellows of the American Institute for Medical and Biological Engineering. Rosen was nominated, reviewed and elected by peers in recognition of his contributions to innovation in cancer treatment as a physician, scientist, educator and administrator.
Tanya Dorff has joined City of Hope as an associate clinical professor in the Department of Medical Oncology, heading the genitourinary cancers program. She was previously at USC Keck School of Medicine, where she served as an associate professor of clinical medicine in the Department of Medicine.
Benjamin Djulbegovic, a professor and director of research in City of Hope's Department of Supportive Care Medicine, was named director of Evidence-based Medicine and Comparative Effectiveness Research, a new core program here at City of Hope created in response to an increasing realization that successful health care delivery and continuing improvement of patient outcomes depends on full integration of research, education and clinical practice.
Johnson & Johnson Innovation announced a five-year alliance with Boston University to accelerate lung cancer research.
Mark Kochevar, associate director for administration and finance at the University of Colorado Cancer Center retired on May 31, 2018, after a career of 41 years in cancer research administration. Kochevar began his career as the assistant administrative officer for the Clinical Oncology Program in the NCI's Division of Cancer Treatment in May 1977.
